Skip to main content

Recombinant Human GLOD4 protein is a Human Full Length protein, in the 1 to 298 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, MS.

Be the first to review this product! Submit a review

Images

SDS-PAGE - Recombinant Human GLOD4 protein (AB109939), expandable thumbnail

Key facts

Purity
>95% SDS-PAGE
Expression system
Escherichia coli
Tags
His tag N-Terminus
Applications
SDS-PAGE, MS
Biologically active
No

Amino acid sequence

M G S S H H H H H H S S G L V P R G S H M A A R R A L H F V F K V G N R F Q T A R F Y R D V L G M K V L R H E E F E E G C K A A C N G P Y D G K W S K T M V G F G P E D D H F V A E L T Y N Y G V G D Y K L G N D F M G I T L A S S Q A V S N A R K L E W P L T E V A E G V F E T E A P G G Y K F Y L Q N R S L P Q S D P V L K V T L A V S D L Q K S L N Y W C N L L G M K I Y E K D E E K Q R A L L G Y A D N Q C K L E L Q G V K G G V D H A A A F G R I A F S C P Q K E L P D L E D L M K R E N Q K I L T P L V S L D T P G K A T V Q V V I L A D P D G H E I C F V G D E A F R E L S K M D P E G S K L L D D A M A A D K S D E W F A K H N K P K A S G

Reactivity data

Application
SDS-PAGE
Reactivity
Reacts
Dilution info
-
Notes

-

Application
MS
Reactivity
Reacts
Dilution info
-
Notes

-

Alternative names

Recommended products

Recombinant Human GLOD4 protein is a Human Full Length protein, in the 1 to 298 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, MS.

Key facts

Purity
>95% SDS-PAGE
Expression system
Escherichia coli
Applications
SDS-PAGE, MS
Accession
Q9HC38-1
Animal free
No
Species
Human
Concentration
Loading...
Storage buffer

pH: 8
Constituents: 20% Glycerol (glycerin, glycerine), 0.316% Tris HCl, 0.058% Sodium chloride, 0.0154% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

Sequence info

Amino acid sequence

M G S S H H H H H H S S G L V P R G S H M A A R R A L H F V F K V G N R F Q T A R F Y R D V L G M K V L R H E E F E E G C K A A C N G P Y D G K W S K T M V G F G P E D D H F V A E L T Y N Y G V G D Y K L G N D F M G I T L A S S Q A V S N A R K L E W P L T E V A E G V F E T E A P G G Y K F Y L Q N R S L P Q S D P V L K V T L A V S D L Q K S L N Y W C N L L G M K I Y E K D E E K Q R A L L G Y A D N Q C K L E L Q G V K G G V D H A A A F G R I A F S C P Q K E L P D L E D L M K R E N Q K I L T P L V S L D T P G K A T V Q V V I L A D P D G H E I C F V G D E A F R E L S K M D P E G S K L L D D A M A A D K S D E W F A K H N K P K A S G
Accession
Q9HC38
Protein length
Full Length
Predicted molecular weight
35.3 kDa
Amino acids
1 to 298
Nature
Recombinant
Tags
His tag N-Terminus

Specifications

Form
Liquid
Additional notes

ab109939 was purified using conventional chromatography.

General info

Sequence similarities

Belongs to the glyoxalase I family.

Subcellular localisation
Mitochondrion

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

GLOD4 also known as Glyoxalase Domain Containing 4 is a protein with a significant role in cellular processes. It has a molecular mass of approximately 18 kDa. This protein expresses mainly in the liver brain and kidneys indicating its involvement in multiple organ systems. GLOD4 contains characteristic glyoxalase domains which facilitate its biochemical actions. Studies suggest that GLOD4 structurally participates in stress response and detoxification pathways due to these domain properties.

Biological function summary

Glyoxalase Domain Containing 4 plays important roles in the detoxification of methylglyoxal a byproduct of glycolysis that can be harmful at high levels. GLOD4 does not function alone; it acts as part of the glyoxalase system which includes other Gly and Gly-related enzymes to efficiently convert toxic metabolites into non-toxic substances. Its enzymatic actions support the maintenance of cellular homeostasis and protection against glycation end-products that are damaging to cellular structures.

Pathways

Glyoxalase Domain Containing 4 operates within key metabolic routes like the glycolytic pathway and the detoxification pathway. It collaborates with enzymes like Glyoxalase I and Glyoxalase II in the aforementioned glyoxalase system to perform its roles. The action within these pathways helps reduce oxidative stress aiding in the prevention of cellular damage. GLOD4’s interaction with these enzymes and pathways highlights its importance in maintaining cellular integrity under physiological and stress conditions.

Associated diseases and disorders

Elevated Glyoxalase Domain Containing 4 expression links to conditions such as diabetes and neurodegenerative disorders. Changes in GLOD4 levels often correspond with disruptions in methylglyoxal metabolism and oxidative stress common in these diseases. Studies also indicate relationships among GLOD4 insulin signaling and proteins such as Glyoxalase I suggesting a connection to the metabolic disturbances found in diabetes. GLOD4's involvement in detoxification pathways also affects the pathogenesis of neurodegenerative diseases potentially influencing cell survival and neuroprotection mechanisms.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • SDS-PAGE - Recombinant Human GLOD4 protein (ab109939), expandable thumbnail

    SDS-PAGE - Recombinant Human GLOD4 protein (ab109939)

    15% SDS-PAGE analysis of 3μg ab109939.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com